BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31759773)

  • 21. Deprivation and access to treatment for colorectal cancer in Southeast Scotland 2003-2009.
    Paterson HM; Mander BJ; Muir P; Phillips HA; Wild SH
    Colorectal Dis; 2014 Feb; 16(2):O51-7. PubMed ID: 24119140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital.
    Prueksaritanond N; Chantape W
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMI.
    Billingsley CC; Cansino C; O'Malley DM; Cohn DE; Fowler JM; Copeland LJ; Backes FJ; Salani R
    Gynecol Oncol; 2016 Mar; 140(3):405-8. PubMed ID: 26801939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation-related toxicities and outcomes in endometrial cancer: are obese women at a disadvantage?
    Smits A; McGrane J; Lopes A; Kent E; Bekkers R; Massuger L; Simpson N; Galaal K
    Int J Clin Oncol; 2017 Oct; 22(5):945-953. PubMed ID: 28620815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of BMI on surgical complications and outcomes in endometrial cancer surgery--an institutional study and systematic review of the literature.
    Bouwman F; Smits A; Lopes A; Das N; Pollard A; Massuger L; Bekkers R; Galaal K
    Gynecol Oncol; 2015 Nov; 139(2):369-76. PubMed ID: 26407479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Significance of Lymphovascular Space Invasion in the Absence of Lymph Node Metastases in Early-Stage Endometrial Cancer.
    Cusano E; Myers V; Samant R; Sudai T; Keller A; Le T; E C; Grimes S; Xu Y
    Int J Gynecol Cancer; 2018 Jun; 28(5):890-894. PubMed ID: 29538248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma.
    Zhang GY; Wu LY; Li B; Huang MN; Zhang R; Li XG
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):309-16. PubMed ID: 23540792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
    Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA
    Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.
    Chattopadhyay S; Cross P; Nayar A; Galaal K; Naik R
    Int J Gynecol Cancer; 2013 May; 23(4):690-7. PubMed ID: 23518862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum HE4 as a prognostic marker in endometrial cancer--a population based study.
    Brennan DJ; Hackethal A; Metcalf AM; Coward J; Ferguson K; Oehler MK; Quinn MA; Janda M; Leung Y; Freemantle M; ; Webb PM; Spurdle AB; Obermair A
    Gynecol Oncol; 2014 Jan; 132(1):159-65. PubMed ID: 24211402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Initial estimation effect of body mass on survival of patients with endometrial carcinoma].
    Studziński Z; Branicka D
    Ginekol Pol; 1999 Feb; 70(2):81-7. PubMed ID: 10349812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thirty-day postoperative mortality for endometrial carcinoma in England: a population-based study.
    Gildea C; Nordin A; Hirschowitz L; Poole J
    BJOG; 2016 Oct; 123(11):1853-61. PubMed ID: 26924123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.
    Creutzberg CL; van Putten WL; Koper PC; Lybeert ML; Jobsen JJ; Wárlám-Rodenhuis CC; De Winter KA; Lutgens LC; van den Bergh AC; van de Steen-Banasik E; Beerman H; van Lent M
    Lancet; 2000 Apr; 355(9213):1404-11. PubMed ID: 10791524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inequalities in health? An update on the effect of social deprivation for patients with breast cancer in South East Wales.
    Boyce K; White C; Hunt P; Abel N; James Z; Micic T; Gomez KF
    Surgeon; 2019 Apr; 17(2):88-96. PubMed ID: 29936016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer.
    Everett E; Tamimi H; Greer B; Swisher E; Paley P; Mandel L; Goff B
    Gynecol Oncol; 2003 Jul; 90(1):150-7. PubMed ID: 12821356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjusted indices of multiple deprivation to enable comparisons within and between constituent countries of the UK including an illustration using mortality rates.
    Abel GA; Barclay ME; Payne RA
    BMJ Open; 2016 Nov; 6(11):e012750. PubMed ID: 27852716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Social deprivation does not affect lung cancer stage at presentation or disease outcome.
    Cheyne L; Taylor A; Milton R; Fear J; Callister ME
    Lung Cancer; 2013 Aug; 81(2):247-51. PubMed ID: 23570796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body mass index as a prognostic factor in endometrioid adenocarcinoma of the endometrium.
    Gates EJ; Hirschfield L; Matthews RP; Yap OW
    J Natl Med Assoc; 2006 Nov; 98(11):1814-22. PubMed ID: 17128692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
    Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
    J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.